Who owns ARTIVION, INC. (AORT)? Elite investor 13F holders

3 tracked elite investors reported holding ARTIVION, INC as of 2026-09-30, including D.E. Shaw, First Eagle Investment Management, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Health Care Equipment & Services

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawARTIVION INCSHARE2026-09-302026-11-16 00:00:0011300989.00 USD495223.000000SharesaddOriginal filing
First Eagle Investment ManagementARTIVION INCSHARE2026-09-302026-11-10 00:00:008617014.00 USD377608.000000SharesaddOriginal filing
Renaissance Technologies LLCARTIVION INCSHARE2026-09-302026-11-12 00:00:00248738.00 USD10900.000000SharesreduceOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown